What You Should Know: - Covera Health, Inc. and Nuance Communications, Inc., today introduced the Quality Care Collaborative (QCC), the first national program that brings together payers, providers, and self-insured employers to support radiology quality improvement initiatives at scale. - The QCC joins Covera’s clinical intelligence platform and Nuance’s Precision Imaging Network™ to enable providers, payers, and employers to work together in a
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know: - H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development - As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository. Integrating Clinical Trial Data Sources to Intelligence Platforms Lokavant is a clinical
Read More
UPMC Spins Out Realyze Intelligence for AI-Based Clinical Intelligence Platform
What You Should Know: - UPMC has launched Realyze Intelligence, a company that uses artificial intelligence and natural language processing to identify precise patient populations with chronic diseases and cancer to ensure they receive the most beneficial treatments. - Founded by Gilan El Saadawi, M.D., Ph.D and Aaron Brauser founded in conjunction with UPMC Enterprises, the innovation and commercialization arm of UPMC. - The U.S. healthcare industry spends
Read More
KPMG, Waystar Integrates Social Determinants of Health Data to Clinical Intelligence Platform
KPMG announced it is integrating social determinants of health (SDoH) data from revenue cycle provider Waystar to KPMG’s Clinical Intelligence (KCI) platform. The integration will harness SDoH data that can help overcome obstacles to medical treatment and affect outcomes to help with care coordination.The Impact of Social Determinants of Health DataSocial, environmental and economic factors – such as transportation, housing, nutrition, and education level – can have a big impact upon medical
Read More
Decisio Health Lands $4.5M for FDA-Cleared Clinical Intelligence Platform
Decisio Health, a Houston-based healthcare software company that helps acute-care provider organizations continually improve their clinical processes, announced today that it has raised $4.5 million in Series B funding. The round was led by DECLATEX, LLC with participation by the University of Texas Horizon Fund. The company also added Larry Lawson, founder of eCardio, as an investor and board member.In addition to the funding round, the company has launched their clinical intelligence
Read More
